Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
about
Systemic delivery of β-blockers via transdermal route for hypertensionGanglionic GFAP + glial Gq-GPCR signaling enhances heart functions in vivoA comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients.A smart library of epoxide hydrolase variants and the top hits for synthesis of (S)-β-blocker precursors.3-[4-(2-Amino-2-oxoeth-yl)phen-oxy]-2-hy-droxy-N-isopropyl-propanaminium 1,1'-binaphthyl-2,2'-diyl phosphate.Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting.Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response MethodologyIdentification of differentially secreted proteins using two-dimensional liquid chromatography/tandem mass spectrometry in vascular smooth muscle cells incubated with S- and R-atenolol.Chromatographic comparison of atenolol separation in reaction media on cellulose tris-(3,5-dimethylphenylcarbamate) chiral stationary phase using ultra fast liquid chromatography.Bioassay, determination and separation of enantiomers of atenolol by direct and indirect approaches using liquid chromatography: A review.Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity
P2860
Q26772083-B76EEE61-F5CF-48E7-A577-6DDA90840129Q30354373-8C179B09-48A4-4535-BA31-A21126BA466AQ34349839-C2131D20-A1A8-4822-8B26-295D9772485DQ35171050-A4AEDB8E-7673-430A-AABD-5CED414DC11CQ39573108-F3772AAA-90D3-40FB-898E-21054200A0EDQ39892404-96FBFB3F-3832-4752-A2F7-FACF5D28B1FFQ41888180-A8284F9A-4390-4B54-8B25-A2FD977F58F2Q43058801-FF15188E-3455-4678-A868-1087D9C31C6FQ45419872-F632B751-6C49-4225-B95F-AC6B1F41F9EFQ48348991-63B0BF89-834B-4492-B2C8-2BC4E66C9AA4Q58691462-D295951A-C67F-4047-82FC-6210FD30AA08
P2860
Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Stereoselective features of (R ...... d radioligand binding studies.
@ast
Stereoselective features of (R ...... d radioligand binding studies.
@en
Stereoselective features of (R ...... d radioligand binding studies.
@nl
type
label
Stereoselective features of (R ...... d radioligand binding studies.
@ast
Stereoselective features of (R ...... d radioligand binding studies.
@en
Stereoselective features of (R ...... d radioligand binding studies.
@nl
prefLabel
Stereoselective features of (R ...... d radioligand binding studies.
@ast
Stereoselective features of (R ...... d radioligand binding studies.
@en
Stereoselective features of (R ...... d radioligand binding studies.
@nl
P2093
P356
P1433
P1476
Stereoselective features of (R ...... d radioligand binding studies.
@en
P2093
P356
10.1002/CHIR.530050104
P577
1993-01-01T00:00:00Z